West Pharmaceutical Services, Inc. (WST)
After hours:
| Previous Close | 368.35 |
| Open | 367.14 |
| Bid | 325.80 x 800 |
| Ask | 401.95 x 800 |
| Day's Range | 363.48 - 369.64 |
| 52 Week Range | 310.42 - 415.73 |
| Volume | |
| Avg. Volume | 527,218 |
| Market Cap | 26.841B |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | 48.31 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.80 (0.22%) |
| Ex-Dividend Date | Jul 31, 2024 |
| 1y Target Est | N/A |
- PR Newswire
West to Participate in Upcoming Investor Conference
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.
- PR Newswire
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial guidance.
- PR Newswire
West to Host First-Quarter 2024 Conference Call
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
